Jump to main content
Jump to site search

Issue 32, 2011
Previous Article Next Article

Development of target-specific multimodality imaging agent by using hollow manganese oxide nanoparticles as a platform

Author affiliations

Abstract

A platform protocol developed based on the hollow manganese oxide nanoparticles provided multimodal diagnostic agents, which allow the selectively detect vulva cancer with T1-weighted in vivo MRI.

Graphical abstract: Development of target-specific multimodality imaging agent by using hollow manganese oxide nanoparticles as a platform

Back to tab navigation

Supplementary files

Publication details

The article was received on 20 May 2011, accepted on 27 Jun 2011 and first published on 15 Jul 2011


Article type: Communication
DOI: 10.1039/C1CC12961A
Citation: Chem. Commun., 2011,47, 9176-9178
  •   Request permissions

    Development of target-specific multimodality imaging agent by using hollow manganese oxide nanoparticles as a platform

    T. Ha, H. J. Kim, J. Shin, G. H. Im, J. W. Lee, H. Heo, J. Yang, C. M. Kang, Y. S. Choe, J. H. Lee and I. S. Lee, Chem. Commun., 2011, 47, 9176
    DOI: 10.1039/C1CC12961A

Search articles by author

Spotlight

Advertisements